SK
JAZZ icon

Seth Klarman’s Jazz Pharmaceuticals JAZZ Stock Holding History

Seth Klarman’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,274,248
Closed -$136M – 24
2024
Q2 		$136M Buy
1,274,248
+440,552
+53% +$48.4M 3.74% 9
2024
Q1 		$100M Hold
833,696
– – 2.75% 11
2023
Q4 		$103M Buy
833,696
+160,000
+24% +$20M 2.24% 12
2023
Q3 		$87.2M Hold
673,696
– – 1.67% 16
2023
Q2 		$83.5M Buy
673,696
+195,000
+41% +$26.2M 1.49% 16
2023
Q1 		$70M Buy
+478,696
New +$70.8M 1.2% 17

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Seth Klarman's JAZZ Position: Q3 2024 in Review

Seth Klarman sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2024, closing a stake of 1,274,248 shares — an estimated $136M sold.

Seth Klarman first reported a position in JAZZ in Q1 2023 and held it in 6 quarters. The position peaked at $136M in Q2 2024. 478 funds tracked by Wall St. Rank hold JAZZ as of Q3 2024.

  • Seth Klarman reported no remaining Jazz Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Seth Klarman sold 1,274,248 Jazz Pharmaceuticals shares in Q3 2024, an estimated $136M.
  • Seth Klarman first reported a position in Jazz Pharmaceuticals in Q1 2023 and held it in 6 quarters.
  • Seth Klarman's Jazz Pharmaceuticals position peaked at $136M in Q2 2024.
  • 478 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2024.

Based on Baupost Group's 13F filing for Q3 2024, filed 13 Nov 2024.